Hidenori Takahashi

USPTO Granted Patents = 17 (Patent Applications = 4)

CIPO Patents = 1

EPO Patents = 3 (Patent Applications = 4)

Average Co-Inventor Count = 3.5

ph-index = 5

Forward Citations = 125(Granted Patents)

Location History:

Kamifukuoka, JP (2004)
Kamifukukoka, JP (2006)
Saitama, JP (1985 - 2012)
Tokyo, JP (2002 - 2017)
Ota-ku, JP (2022 - 2024)
Fujimino, JP (2022 - 2024)

Company Filing History:

Daiichi Sankyo Company, Limited

patents

4. 3 out of 950

Chugai Seiyaku Kabushiki Kaisha

patents

5. 1 out of 9

Kddi Submarine Cable Systems Inc.

patents

Years Active: 1985-2024

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12024547 - KLK5 inhibitory peptide (2024-07-02),

2. 11966083 - Communication device and communication system (2024-04-23),

3. 11292828 - KLK5 inhibitory peptide (2022-04-05),

4. 11245468 - Measurement apparatus of optical communication system (2022-02-08),

5. 9670173 - Dicarboxylic acid compound (2017-06-06),

6. 9617232 - Dicarboxylic acid compound (2017-04-11),

7. 8182115 - Light source device (2012-05-22),

8. 7595946 - Imaging apparatus and portable apparatus (2009-09-29),

9. 7580133 - Interferometric apparatus for measuring moving object and optical interferometry method for measuring moving object (2009-08-25),

10. 7248013 - Motor drive circuit (2007-07-24),

11. 7035495 - Chromatic dispersion device (2006-04-25),

12. 6907152 - Ring resonator (2005-06-14),

13. 6801692 - Optical coupling structure (2004-10-05),

14. 6731836 - Dispersion compensator (2004-05-04),

15. 6335464 - Process for selectively oxidizing primary hydroxyl groups of organic compounds, and resin containing adsorbed catalyst for use therein (2002-01-01),

Title: Hidenori Takahashi: Innovator in Biotechnology and Communication Systems

Introduction

Hidenori Takahashi is a prominent inventor based in Saitama, Japan. He has made significant contributions to the fields of biotechnology and communication systems. With a total of 17 patents, his work has had a considerable impact on various industries.

Latest Patents

One of Takahashi's latest innovations is the development of KLK5 inhibitory peptide - SPINK2 mutant peptide conjugates. These conjugates are designed to inhibit KLK5 and are characterized as Fc fusion peptides. In certain embodiments, the Fc region of these fusion peptides is derived from human IgG1 or a fragment thereof. The conjugates include specific amino acid sequences from SEQ ID NOs: 34, 36, 38, 40, 42, 44, 46, 48, 96, 50, 52, 54, 56, 58, or 60. Additionally, he has provided pharmaceutical compositions that incorporate these KLK5 inhibitory peptide conjugates, which are useful for treating KLK5-related diseases.

Another notable patent involves a communication device and communication system. This device features a switching unit connected to both a transmission unit and a reception unit, along with transmission and reception ports. The switching unit can be set in two states, allowing for flexible communication configurations. A monitoring unit is included to assess the light level from the ports, while a control unit adjusts the switching unit based on the monitored light levels.

Career Highlights

Throughout his career, Hidenori Takahashi has worked with notable companies such as KDDI Corporation and Fujinon Corporation. His experience in these organizations has contributed to his expertise in developing innovative technologies.

Collaborations

Takahashi has collaborated with talented individuals in his field, including Masashi Usami and Kosuke Nishimura. These partnerships have fostered a creative environment that has led to groundbreaking inventions.

Conclusion

Hidenori Takahashi is a distinguished inventor whose work in biotechnology and communication systems continues to influence various sectors. His innovative patents and collaborations highlight his commitment to advancing technology and improving lives.

This text is generated by artificial intelligence and may not be accurate.